Effect of Ozone Gel on Treatment of Chronic Periodontitis
Launched by OCTOBER 6 UNIVERSITY · Feb 14, 2014
Trial Information
Current as of May 14, 2025
Completed
Keywords
ClinConnect Summary
In this study, the investigators tested the effect of ozone gel as a local delivery system in treatment of chronic periodontitis in term of probing pocket depth reduction, mean gain in clinical attachment level, a more rise in BD values as well as greater reduction in SOD activity compared to scaling and root planing (SRP) alone.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. The participant's age ranged between 30 and 60 years.
- • 2. All of the patients suffered from chronic periodontitis with attachment loss ≥ 5mm.
- • 3. Willingness to participate and sign the informed consent.
- Exclusion Criteria:
- • 1. Any systemic disease that affect the periodontium.
- • 2. Pregnancy, lactation, postmenopausal women
- • 3. People who take anti-inflammatory drugs, antibiotics or vitamins within the previous 3 month.
- • 4. People who use mouth washes regularly
- • 5. Heavy smoking (\> 10 cigarettes/day)
- • 6. History of alcohol abuse.
- • 7. Participation in other clinical trials.
About October 6 University
October 6 University is a prestigious educational institution dedicated to advancing medical research and clinical trials. With a strong emphasis on innovation and excellence, the university fosters a collaborative environment that integrates cutting-edge scientific research with practical clinical applications. Its commitment to improving healthcare outcomes is reflected in its comprehensive approach to clinical trials, where it engages in rigorous methodologies and ethical standards to ensure the safety and efficacy of new treatments. Through its dedicated research facilities and highly qualified personnel, October 6 University aims to contribute significantly to the global medical community and enhance patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Trial Officials
Enas Elgendy, ph.D
Principal Investigator
October 6 University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials